ABCG2 p.Asn387Ala
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 20739628
[PubMed]
Ni Z et al: "Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport."
No.
Sentence
Comment
12
N387A and Q398A displayed significantly impaired efflux for mitoxantrone and Hoechst 33342, but not for BODIPY-prazosin.
X
ABCG2 p.Asn387Ala 20739628:12:0
status: VERIFIED15 Furthermore, N629A was associated with a marked increase, and N387A and T402A with a significant reduction, in BCRP ATPase activity.
X
ABCG2 p.Asn387Ala 20739628:15:62
status: VERIFIED68 The forward primers used for mutagenesis were as follows: N387A (5=- AAG CGT TCA TTC AAA GCC TTG CTG GGT AAT CCC-3=), Q398A (5=-CAG GCC TCT ATA GCT GCG ATC ATT GTC ACA GTC-3=), T402A (5=-GCT CAG ATC ATT GTC GCA GTC GTA CTG GGA CTG-3=), N629A (5=-CTG GGG CTT GTG GAA GGC TCA CGT GGC CTT GGC TTG-3=), T642A (5=-GAT TGT TAT TTT CCT CGC AAT TGC CTA CCT GAA ATT G-3=), and Y645F (5=-TTC CTC ACA ATT GCC TTC CTG AAA TTG TTA TTT C-3=).
X
ABCG2 p.Asn387Ala 20739628:68:58
status: VERIFIED162 The levels of N387A, Q398A, T402A, N629A, T642A, and Y645F, determined by immunoblotting of whole cell lysates using beta-actin as an internal standard, were ϳ4.4-, 4.5-, 3.1-, 0.4-, 1.3-, and 1.5-fold that of wild-type BCRP (Fig. 2, A and B).
X
ABCG2 p.Asn387Ala 20739628:162:14
status: VERIFIED191 N387A and Q398A also showed significantly reduced efflux activities for MX and Hoechst 33342 by 40-80%, but were fully active in transporting BODIPY-prazosin.
X
ABCG2 p.Asn387Ala 20739628:191:0
status: VERIFIED200 Representative areas of HEK-293 cells expressing wild-type BCRP and the mutants N387A, Q398A, T402A, N629A, T642A, and Y645F are shown.
X
ABCG2 p.Asn387Ala 20739628:200:80
status: VERIFIED217 Thus N387A, Q398A, and T402A exhibited a significantly lower resistance to MX than wild-type BCRP, whereas N629A displayed an approximately threefold increase in resistance to MX.
X
ABCG2 p.Asn387Ala 20739628:217:5
status: VERIFIED224 The Km values of N387A, T402A, T642A, and Y645F were comparable to that of wild-type protein; however, the Km values of Q398A and N629A were decreased by ϳ50-60%.
X
ABCG2 p.Asn387Ala 20739628:224:17
status: VERIFIED226 After normalization to the BCRP protein levels, the Vmax values of N387A, Q398A, and T402A were approximately one-half of that of wild-type BCRP, whereas the Vmax value of N629A was increased by ϳ90%.
X
ABCG2 p.Asn387Ala 20739628:226:67
status: VERIFIED228 In contrast, the Vmax/Km values of N387A and T402A were decreased by ϳ50%.
X
ABCG2 p.Asn387Ala 20739628:228:35
status: VERIFIED231 FTC-inhibitable efflux activities of HEK-293 cells stably expressing wild-type and mutant BCRP Mitoxantrone BODIPY-Prazosin Hoechst 33342 ⌬F ⌬F= Ratio ⌬F ⌬F= Ratio ⌬F ⌬F= Ratio Wild-type BCRP 10.6 Ϯ 0.6 10.6 Ϯ 0.6 1.0 12.5 Ϯ 4.3 12.5 Ϯ 4.3 1.0 2150.0 Ϯ 25.5 2150.0 Ϯ 25.5 1.0 N387A 11.3 Ϯ 0.5 2.5 Ϯ 0.1* 0.2 54.5 Ϯ 5.8 12.3 Ϯ 1.3 1.0 5,024.7 Ϯ 570.5 1,131.7 Ϯ 128.5* 0.5 Q398A 28.1 Ϯ 5.2 6.3 Ϯ 1.2* 0.6 69.3 Ϯ 10.6 15.5 Ϯ 2.4 1.2 4,206.7 Ϯ 252.1 941.1 Ϯ 56.4* 0.4 T402A 12.3 Ϯ 2.4 4.0 Ϯ 0.8* 0.4 4.5 Ϯ 1.8 1.5 Ϯ 0.6* 0.1 999.3 Ϯ 352.9 322.4 Ϯ 113.8* 0.1 N629A 19.3 Ϯ 3.7 46.0 Ϯ 8.8* 4.3 12.8 Ϯ 1.5 30.5 Ϯ 3.6* 2.4 2,681.0 Ϯ 370.5 6,383.3 Ϯ 882.1* 3.0 T642A 17.0 Ϯ 0.3 12.9 Ϯ 0.2 1.2 15.4 Ϯ 1.3 11.8 Ϯ 1.0 0.9 1,860.7 Ϯ 462.3 1,420.4 Ϯ 352.9* 0.7 Y645F 16.8 Ϯ 2.3 11.6 Ϯ 1.6 1.1 15.1 Ϯ 4.6 10.4 Ϯ 3.2 0.8 1,358.7 Ϯ 35.5 937.0 Ϯ 24.5* 0.4 Values are means Ϯ SD of 3 independent experiments.
X
ABCG2 p.Asn387Ala 20739628:231:354
status: VERIFIED238 Relative drug resistance of HEK-293 cells expressing wild-type and mutant BCRP MX SN-38 Dox Rho-123 IC50, nM RR (ratio) IC50, nM RR (ratio) IC50, nM RR IC50, nM RR pcDNA control 8.5 Ϯ 0.6 2.3 Ϯ 0.28 125.6 Ϯ 32.0 1,881 Ϯ 168.2 Wild-type BCRP 64.8 Ϯ 3.9 7.6 (1.0) 89.7 Ϯ 5.4 39.0 (1.0) 168.0 Ϯ 24.5 1.3 3,341 Ϯ 267.4 1.8 N387A 54.8 Ϯ 6.3 6.4 (0.2)* 44.8 Ϯ 6.3 19.5 (0.1)* 120.4 Ϯ 31.6 1.0 3,279 Ϯ 436.8 1.7 Q398A 49.9 Ϯ 4.6 5.9 (0.2)* 71.6 Ϯ 4.3 31.1 (0.2)* 173.4 Ϯ 36.5 1.4 2,534 Ϯ 376.5 1.3 T402A 43.3 Ϯ 7.6 5.1 (0.2)* 63.0 Ϯ 5.4 27.4 (0.2)* 129.4 Ϯ 31.4 1.0 2,140 Ϯ 210.7 1.1 N629A 76.5 Ϯ 12.3 9.0 (2.8)* 108.3 Ϯ 12.3 47.1 (2.9)* 164.6 Ϯ 14.8 1.3 3,051 Ϯ 286.5 1.6 T642A 50.0 Ϯ 9.5 5.9 (0.6) 49.9 Ϯ 9.9 21.7 (0.4)* 156.1 Ϯ 20.0 1.2 1,393 Ϯ 221.6 0.7 Y645F 42.8 Ϯ 6.8 5.0 (0.5)* 44.8 Ϯ 6.3 19.5 (0.3)* 132.4 Ϯ 18.4 1.1 1,846 Ϯ 206.2 1.0 The IC50 values shown are means Ϯ SD of 3 independent experiments.
X
ABCG2 p.Asn387Ala 20739628:238:367
status: VERIFIED251 In contrast, N387A and Q398A were associated with a slight decrease in 5D3-phycoerythrin fluorescence.
X
ABCG2 p.Asn387Ala 20739628:251:13
status: VERIFIED254 In particular, significant differences in 5D3 binding were observed between wild-type BCRP and the mutants N387A, Q398A, T402A, and N629A at certain prazosin concentrations (Fig. 5).
X
ABCG2 p.Asn387Ala 20739628:254:107
status: VERIFIED274 Kinetic parameters of ATP hydrolysis by wild-type and mutant BCRP Wild-type BCRP N387A Q398A T402A N629A T642A Y645F Vmax, nmol Pi ·min-1 ·mg protein-1 14.5 Ϯ 1.9 16.9 Ϯ 1.5 14.9 Ϯ 0.93 17.4 Ϯ 1.7 11.5 Ϯ 1.1 17.9 Ϯ 1.9 14.5 Ϯ 1.9 Vmax normalized to BCRP protein level, nmol Pi ·min-1 ·mg protein-1 14.5 Ϯ 1.9 7.0 Ϯ 0.63 6.5 Ϯ 0.41 8.3 Ϯ 0.81 28.0 Ϯ 2.7 16.3 Ϯ 1.7 12.0 Ϯ 1.6 Km for ATP, mM 0.89 Ϯ 0.40 0.90 Ϯ 0.27 0.48 Ϯ 0.12 1.1 Ϯ 0.35 0.40 Ϯ 0.15 0.93 Ϯ 0.34 0.89 Ϯ 0.43 Vmax/Km, nmol Pi ·min-1 ·mg protein-1 ·mM-1 16.3 7.8 13.5 7.5 70.0 17.5 13.5 Values are means Ϯ SD of 3 independent determinations.
X
ABCG2 p.Asn387Ala 20739628:274:81
status: VERIFIED282 Significant differences (P Ͻ 0.05) in 5D3 binding analyzed by the Student`s t-test were observed between wild-type BCRP and the mutant N387A, Q398A, T402A, or N629A at certain prazosin concentrations and are marked (*) on the right of respective data points.
X
ABCG2 p.Asn387Ala 20739628:282:141
status: VERIFIED318 C1107POLAR Replacement of Asn387 and Gln398 with Ala significantly but selectively impaired the efflux of MX and Hoechst 33342, but not of BODIPY-prazosin, and showed lower resistance to MX and SN-38 (Tables 1 and 2), suggesting that mutations of the two polar residues influenced substrate specificity.
X
ABCG2 p.Asn387Ala 20739628:318:27
status: VERIFIEDX
ABCG2 p.Asn387Ala 20739628:318:97
status: NEW323 However, we showed that mutation of Asn387 with Ala did not impair BCRP expression, folding, or trafficking to the plasma membrane to any significant extent.
X
ABCG2 p.Asn387Ala 20739628:323:36
status: VERIFIED342 N387A, Q398A, and T402A also showed changes in Km and/or Vmax for ATP hydrolysis (Table 3).
X
ABCG2 p.Asn387Ala 20739628:342:0
status: VERIFIED350 Prazosin differentially increased 5D3 binding to wild-type BCRP, N629A, T642A, and Y645F, whereas 5D3 binding to N387A and Q398A was slightly decreased (Fig. 5).
X
ABCG2 p.Asn387Ala 20739628:350:113
status: VERIFIED